Question 1

How do lean funds use this?

Accepted Answer

Partners and principals use it as external scientific diligence on a live deal: make the claims explicit, score support and contradiction with citations, and walk into IC or syndicate close with an inspectable memo — same OpEx habit as a KOL or specialist consult, with a clearer artifact.

Question 2

How is this different from a KOL call?

Accepted Answer

A KOL call is expert judgment, often captured in notes. We produce a written, claim-by-claim evidence ledger you can share with partners and co-investors. Many funds use both: our memo focuses the KOL questions.

Question 3

How is this different from ChatGPT or a generic AI brief?

Accepted Answer

Fluent summaries are not diligence. We require falsifiable claims, deliberate search for contradicting evidence, graded confidence, and human review before anything is delivered as a conclusion.

Question 4

What budget line does this fit?

Accepted Answer

Management-company or deal OpEx — the consulting line you already use for external science help. Entry claim screens start in the low thousands; IC Snapshots typically sit in the mid–high four to low five figures, in band with specialist scientific DD packages.

Question 5

Can you incorporate confidential dataroom materials?

Accepted Answer

Yes. Confidential workflows are available when you need a deeper read on non-public data. Anything published externally reflects only what you approve for release.

Question 6

How do you handle citations and evidence?

Accepted Answer

Every scored claim is tied to sources. Public literature and trial registries are preferred for independent corroboration; company materials are labeled as such. You should be able to click through and inspect.

Question 7

Do founders buy this too?

Accepted Answer

Sometimes — usually after an investor recommends a claim test before a raise. Primary buyers are funds and staffed syndicates with an org budget for diligence.

Question 8

What about publishing an authority page?

Accepted Answer

Optional. Diligence is the product. If useful, the reviewed conclusion can become a durable citation-backed page. Discoverability is a payoff of good diligence content — not the reason to engage.

Questions buyers ask before they engage.

How HDDT creates value

Scope the engagement that fits your decision.

Questions buyers ask before they engage.

How HDDT creates value

How do lean funds use this?+

How is this different from a KOL call?+

How is this different from ChatGPT or a generic AI brief?+

What budget line does this fit?+

Can you incorporate confidential dataroom materials?+

How do you handle citations and evidence?+

Do founders buy this too?+

What about publishing an authority page?+

Scope the engagement that fits your decision.